Triomics just raised. Here's exactly what to do next.
Who to reach, what to say, and why now — on Triomics, plus every funding round, exec hire, and M&A move that follows. Verified, ICP-ranked contacts on demand (email + mobile).
Used by professionals at BlackRock, Oracle, Kleiner Perkins, HubSpot, and other leading firms — built on 10 years of proprietary signal data.
Everyone else gives you a piece
Only Fundz delivers all four.
Triomics raises $22M in Series B funding led by Battery Ventures to enhance its oncology-specific AI platform.
Amount Raised
$22 Million
Round Type
series b
Investors
Description
Triomics has secured $22 million in Series B funding to advance its AI platform designed for oncologists and administrative staff. The funding round was led by Battery Ventures, with participation from Nexus Venture Partners, Lightspeed, and Y Combinator. The investment will help streamline data-heavy tasks in cancer care, improving efficiency for healthcare providers. This approach is crucial as oncology records become increasingly complex.
Related People
1 more contact · See plans
Funding Insights
Based on industry dataWatching Triomics? See every signal — funding, hires, M&A, contracts, sentiment.
Request a demoChoose your plan